Positioning Guselkumab in The Treatment Algorithm of Patients with Crohn’s Disease
Ferdinando D’Amico(Humanitas University), Silvio Danese, Axel Dignaß(Goethe University Frankfurt), Fernando Magro(Universidade do Porto), Ana Gutiérrez(Hospital General Universitario de Alicante Doctor Balmis), Alessandro Armuzzi, Sarah Bencardino(Vita-Salute San Raffaele University), Ailsa Hart(St Mark's Hospital), Laurent Peyrin-Biroulet(Inserm), Bram Verstockt(Universitair Ziekenhuis Leuven)
Cited by 5
Related Papers
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
|Journal of Crohn s and Colitis|2019|1.4k
ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
|Journal of Crohn s and Colitis|2019|1.1k
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k